Indication
Post-traumatic stress disorder
1 clinical trial
2 products
Product
PRAX-114Clinical trial
A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Post-Traumatic Stress DisorderStatus: Terminated, Estimated PCD: 2022-08-01
Product
Placebo